Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine for ischemic chest pain in coronary slow flow syndrome
IRCT20220516054874N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Slow Coronary Flow (SCF) comparing Amlodipine plus common treatment with Placebo plus common treatment (2 arms). Primary endpoints: Pain intensity at 2 months, Number of daily pain episodes at 2 months and 2 more. Started Jun 2022; status: completed.
02
Drugs
amlodipine
03
Conditions
Slow Coronary Flow (SCF)
Beyond the preview
Go deeper on IRCT20220516054874N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220516054874N1.